Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127767121 | 12776712 | 1 | I | 20160916 | 20160923 | 20160923 | EXP | LK-MYLANLABS-2016M1040198 | MYLAN | PUSHPAKUMARA J, KARUNARATHNA P, SIVATHIRAN S, LIYANAGE A, INDRAKUMAR J.. CLOZAPINE INDUCED PANCYTOPENIA LEADING TO SEVERE SEPSIS:AN UNUSUAL EARLY COMPLICATION.. BMC RESEARCH NOTES.. 2015;8:1-4 | 0.00 | Y | 0.00000 | 20160923 | OT | LK | LK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127767121 | 12776712 | 1 | PS | CLOZAPINE. | CLOZAPINE | 1 | 200 MG, QD | Y | U | 75417 | 200 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127767121 | 12776712 | 1 | Schizophrenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127767121 | 12776712 | HO |
| 127767121 | 12776712 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127767121 | 12776712 | Neutropenic sepsis | |
| 127767121 | 12776712 | Pain | |
| 127767121 | 12776712 | Pancytopenia | |
| 127767121 | 12776712 | Pyrexia | |
| 127767121 | 12776712 | Respiratory rate increased | |
| 127767121 | 12776712 | Sinus tachycardia | |
| 127767121 | 12776712 | Subcutaneous abscess |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |